The contributors to the development of fibrosis in AS patients are an imbalance in matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase (MMPs) activity, alongside increases in angiotensin-converting enzyme and transforming growth factor beta1 activity. The gene discussed is TGFB1; the disease is aortic stenosis.